STAT1 and type 1 diabetes mellitus: Furthermore, elevated levels of phosphorylated STAT1/3 in T1D patients correlate with higher expression of inhibitory molecules such as PD-L1, PD-L2, and PD-1, which impact immune regulatory mechanisms (82).